HLA-B*51 | rs76546355 | |||||||
---|---|---|---|---|---|---|---|---|
Characteristic | B*51 + | B*51 − | P -values | OR (95% CI) | AA + GA | GG | P -values | OR (95% CI) |
Male sex, % | 72.2 | 67.0 | 1.54 × 10−1 | 54.4 | 48.6 | 9.07 × 10−2 | ||
Age at onset, years, mean ± SD | 26.3 ± 9.1 | 25.5 ± 10.2 | 3.02 × 10−1 | 26.0 ± 9.1 | 25.8 ± 10.4 | 7.25 × 10−1 | ||
Genital aphthosis, % | 62.8 | 61.2 | 6.96 × 10−1 | 66.5 | 55.6 | 1.05 × 10 −3 | 1.59[1.20-2.09] | |
Skin lesions, % | 59.7 | 53.7 | 1.39 × 10−1 | 56.7 | 52.7 | 2.38 × 10−1 | ||
Ophthalmologic manifestations, % | 63.0 | 62.1 | 8.23 × 10−1 | 59.2 | 61.6 | 4.88 × 10−1 | ||
Joint manifestations, % | 33.9 | 28.2 | 1.31 × 10−1 | 32.0 | 28.9 | 3.32 × 10−1 | ||
Neurological manifestations, % | 5.9 | 6.6 | 2.03 × 10−1 | 5.6 | 4.4 | 8.85 × 10−1 | ||
Vascular involvement, % | 5.3 | 7.5 | 7.36 × 10−1 | 6.3 | 6.0 | 4.35 × 10−1 | ||
Gastrointestinal manifestations, % | 3.3 | 3.1 | 8.79 × 10−1 | 3.6 | 4.4 | 5.28 × 10−1 | ||
Positive pathergy test, % | 51.8 | 40.8 | 7.34 × 10−3 | 1.56 (1.13, 2.16) | 50.2 | 37.5 | 2.31 × 10 −4 | 1.69 (1.28, 2.23) |
Positive family history of BD, % | 10.3 | 5.1 | 2.35 × 10−2 | 2.16 (1.09, 4.27) | 10.9 | 4.6 | 1.59 × 10 −3 | 2.52 (1.40, 4.58) |